Page 3 - Accelerating Access News Today

Utahs Republican incumbents solidified their control of the states four congressional districts Tuesday, each leading their Democratic opponents by at least 40 points, early results show.

The fund will back clinical trials, natural history studies, and regulatory science tools that will give the FDA a greater understanding of the ways that rare diseases can be treated.

SILVER SPRING, Md., Oct. 17, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38

Research for rare diseases including ALS will be supported over the next four years by $38 million in FDA funding.

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has awarded 19 new grants and two new contracts totaling more than $38 million in funding mainly to develop medical products to treat

/PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in...

- ACT for ALS Funding is for an Expanded Access Program to Study SLS-005 in Amyotrophic Lateral Sclerosis Patients Who Do Not Qualify for Clinical Trials NEW YORK, Sept. 30, 2022 /PRNewswire/ --... | September 30, 2022

This Week in Washington: Congress Focuses on FDA User Fee Legislation, Telehealth and Continuing Resolution; Administration Issues Executive Order on Biomanufacturing.

The US FDA and NIH have unveiled a public-private partnership (PPP) to understand and develop treatments for neurodegenerative diseases.

/PRNewswire/ -- Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND),...